Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY21.46
+0.11 (+0.52%)
CN SHH Healthcare Medical - Pharmaceuticals
Address
Yifeng Medical Park 410000
Changsha, CN
Changsha, CN
CEO
Gao Yi
Website
yfdyf.com
IPO
2015-02-17
ISIN CNE100001TS5
Description
Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY21.46
+0.11 (+0.52%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
12M
Beta
0.37
Float Shares
580.20M
Free Float %
47.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.28% | +1.63% | -8.88% | -13.00% | -6.54% | -2.67% | -18.88% | -30.78% | -48.01% | +114.84% | +360.57% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
21.46
DCF (Unlevered)
197.67
+821.1%
DCF (Levered)
154.61
+620.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.62
Grey zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%+1.5% Q1'26: +1.3% (vs Q1'25)
-
EPS growth Medical - Pharmaceuticals: +20.2%+9.7% Q1'26: +11.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%+11.1% ★ Q1'26: +17.1% (vs Q1'25)
-
EBIT margin Medical - Pharmaceuticals: +6.8%+9.8% ★ Q1'26: +11.5% (vs Q1'25)
-
ROIC Medical - Pharmaceuticals: +6.1%+12.2% ★ Q1'26: +15.4% (vs Q1'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%+0.1% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×2.64× Q1'26: 3.64× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 15 Rev. Ana. 14 EPS Ana. |
Dec 2027 15 Rev. Ana. 15 EPS Ana. |
Dec 2028 13 Rev. Ana. 13 EPS Ana. |
Dec 2029 12 Rev. Ana. 11 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.85B
est: 2.66B (+6.8%)
|
3.73B
est: 3.85B (-3.0%)
|
4.81B
est: 4.81B (-0.2%)
|
6.91B
est: 6.54B (+5.7%)
|
10.28B
est: 10.28B (+0.0%)
|
13.14B
est: 13.24B (-0.7%)
|
15.33B
est: 15.42B (-0.6%)
|
19.89B
est: 18.92B (+5.1%)
|
22.59B
est: 23.64B (-4.5%)
|
24.06B
est: 24.70B (-2.6%)
|
24.43B
est: 24.46B (-0.1%)
|
26.51B
25.55B – 27.28B
+8.4% YoY
|
29.09B
27.07B – 31.53B
+9.7% YoY
|
32.31B
32.30B – 32.32B
+11.1% YoY
|
43.95B
41.60B – 46.50B
+36.0% YoY
|
| EBITDA |
239.80M
est: 269.73M (-11.1%)
|
312.98M
est: 389.80M (-19.7%)
|
442.32M
est: 487.51M (-9.3%)
|
587.94M
est: 662.08M (-11.2%)
|
925.25M
est: 1.04B (-11.1%)
|
1.30B
est: 1.34B (-2.8%)
|
1.52B
est: 1.56B (-2.6%)
|
2.11B
est: 1.92B (+10.4%)
|
2.23B
est: 5.88B (-62.1%)
|
2.47B
est: 6.14B (-59.7%)
|
4.35B
est: 6.08B (-28.4%)
|
6.59B
6.35B – 6.78B
+8.4% YoY
|
7.23B
6.73B – 7.84B
+9.7% YoY
|
8.03B
8.03B – 8.04B
+11.1% YoY
|
10.93B
10.34B – 11.56B
+36.0% YoY
|
| EBIT |
212.64M
est: 244.53M (-13.0%)
|
275.22M
est: 353.38M (-22.1%)
|
392.19M
est: 441.96M (-11.3%)
|
517.63M
est: 600.21M (-13.8%)
|
830.53M
est: 943.23M (-11.9%)
|
1.19B
est: 1.22B (-2.0%)
|
1.38B
est: 1.42B (-2.7%)
|
1.93B
est: 1.74B (+11.0%)
|
2.01B
est: 2.45B (-17.7%)
|
2.22B
est: 2.56B (-13.0%)
|
2.39B
est: 2.53B (-5.6%)
|
2.74B
2.64B – 2.82B
+8.4% YoY
|
3.01B
2.80B – 3.26B
+9.7% YoY
|
3.34B
3.34B – 3.34B
+11.1% YoY
|
4.55B
4.30B – 4.81B
+36.0% YoY
|
| Net Income |
175.94M
est: 235.86M (-25.4%)
|
223.89M
est: 248.62M (-9.9%)
|
313.50M
est: 333.02M (-5.9%)
|
416.41M
est: 465.99M (-10.6%)
|
543.75M
est: 582.20M (-6.6%)
|
743.52M
est: 799.69M (-7.0%)
|
887.88M
est: 945.42M (-6.1%)
|
1.26B
est: 1.15B (+10.0%)
|
1.41B
est: 1.50B (-6.2%)
|
1.53B
est: 1.74B (-12.2%)
|
1.68B
est: 1.73B (-2.9%)
|
1.93B
1.87B – 2.04B
+11.6% YoY
|
2.18B
1.93B – 2.57B
+12.9% YoY
|
2.49B
2.23B – 2.96B
+14.1% YoY
|
3.51B
3.26B – 3.77B
+41.1% YoY
|
| SGA |
872.50M
est: 782.03M (+11.6%)
|
1.17B
est: 1.13B (+3.4%)
|
1.49B
est: 1.41B (+5.7%)
|
2.16B
est: 1.92B (+12.6%)
|
3.12B
est: 3.02B (+3.4%)
|
3.71B
est: 3.89B (-4.7%)
|
4.72B
est: 4.53B (+4.2%)
|
5.78B
est: 5.56B (+4.1%)
|
6.45B
est: 5.86B (+10.0%)
|
7.26B
est: 6.13B (+18.6%)
|
1.32B
est: 6.07B (-78.3%)
|
6.57B
6.33B – 6.77B
+8.4% YoY
|
7.21B
6.71B – 7.82B
+9.7% YoY
|
8.01B
8.01B – 8.01B
+11.1% YoY
|
10.90B
10.32B – 11.53B
+36.0% YoY
|
| EPS |
0.22
est: 0.19 (+15.0%)
|
0.26
est: 0.20 (+28.9%)
|
0.34
est: 0.27 (+25.9%)
|
0.45
est: 0.38 (+19.0%)
|
0.57
est: 0.47 (+20.7%)
|
0.77
est: 0.65 (+18.7%)
|
0.89
est: 0.77 (+16.0%)
|
1.05
est: 0.94 (+11.6%)
|
1.17
est: 1.25 (-6.2%)
|
1.26
est: 1.41 (-10.4%)
|
1.38
est: 1.39 (-0.8%)
|
1.61
1.51 – 1.65
+15.4% YoY
|
1.82
1.56 – 2.08
+13.3% YoY
|
2.08
1.80 – 2.40
+14.3% YoY
|
2.84
2.64 – 3.06
+36.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
3.15B
OE per share TTM
2.56
Owner's Yield
12.30%
Maintenance CapEx ratio
0.40%
Maint CapEx / Avg PPE
20.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 45 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck - China New Economy ETF CNEW.AX | 0.86% | 610.2K | 0.95% |
| 2 | abrdn Emerging Markets Dividend Active ETF AGEM | 0.22% | 767.2K | 1.18% |
| 3 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.11% | 41.7K | 0.65% |
| 4 | HSBC MSCI China A UCITS ETF HMCT.L | 0.08% | 112.7K | 0.30% |
| 5 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.03% | 5.6K | 0.65% |
| 6 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.02% | 423.3K | 0.58% |
| 7 | Franklin FTSE China ETF FLCH | 0.01% | 39.2K | 0.19% |
| 8 | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF EMCR | 0.01% | 7.4K | 0.15% |
| 9 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 96.1K | 0.19% |
| 10 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 32.9K | 0.44% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
59.7K
Shares Outstanding
1.21B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gao Yi | Chairman & Chief Executive Officer | — | male |
| Jia Zhang | Vice President | — | male |
| Jianxia Hu | Associate President, Head of Operations of National Regions & Vice President | — | female |
| Jun Yan | Vice President, GM of New Retail Business Group, Head of Digital Center & Associate President | — | male |
| Wei Fan | Secretary | — | male |
| Wei Gu | Executive Vice President | — | male |
| Xiao Zai Xiang | Vice President | — | male |
| Xuemei Wan | Vice President | — | female |
| Yonghui Wang | Vice President & Chief Financial Officer | — | male |
| You Cheng Gao | Executive President & Director | — | male |
| Zhaoxu Zhang | Vice President | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603939.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
